Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Boger

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Journal of the American Chemical Society|July 18, 2001
Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3)D L Boger, J Goldberg, S Silletti, et al.
Current Medicinal Chemistry|October 9, 2002
Fostriecin: chemistry and biologyD S Lewy, C-M Gauss, D R Soenen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivoS Silletti, T Kessler, J Goldberg, et al.
Journal of the American Chemical Society|July 18, 2001
Total syntheses of thiocoraline and BE-22179 and assessment of their DNA binding and biological propertiesD L Boger, S Ichikawa, W C Tse, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Arachidonic acid amide inhibitors of gap junction cell-cell communicationD L Boger, H Sato, A E Lerner, et al.
Bioorganic & Medicinal Chemistry|September 1, 1995
Synthesis of key analogs of bleomycin A2 that permit a systematic evaluation of the linker region: identification of an exceptionally prominent role for the L-threonine substituentD L Boger, S L Colletti, S Teramoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1991
Demonstration of a pronounced effect of noncovalent binding selectivity on the (+)-CC-1065 DNA alkylation and identification of the pharmacophore of the alkylation subunitD L Boger, H Zarrinmayeh, S A Munk, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis of the vancomycin CDE ring systemD L Boger, R T Beresis, O Loiseleur, et al.
The Journal of Organic Chemistry|May 2, 2000
Total synthesis of ningalin B utilizing a heterocyclic azadiene Diels-Alder reaction and discovery of a new class of potent multidrug resistant (MDR) reversal agentsD L Boger, D R Soenen, C W Boyce, et al.
Tetrahedron|September 28, 2018
An alternative and convenient strategy for generation of substantial quantities of singly 5'-32P-end-labeled double-stranded DNA for binding studies: development of a protocol for examination of functional features of (+)-CC-1065 and the duocarmycins that contribute to their sequence-selective DNA alkylation propertiesD L Boger, S A Munk, H Zarrinmayeh, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Journal of the American Chemical Society|July 18, 2001
Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3)D L Boger, J Goldberg, S Silletti, et al.
Current Medicinal Chemistry|October 9, 2002
Fostriecin: chemistry and biologyD S Lewy, C-M Gauss, D R Soenen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivoS Silletti, T Kessler, J Goldberg, et al.
Journal of the American Chemical Society|July 18, 2001
Total syntheses of thiocoraline and BE-22179 and assessment of their DNA binding and biological propertiesD L Boger, S Ichikawa, W C Tse, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Arachidonic acid amide inhibitors of gap junction cell-cell communicationD L Boger, H Sato, A E Lerner, et al.
Bioorganic & Medicinal Chemistry|September 1, 1995
Synthesis of key analogs of bleomycin A2 that permit a systematic evaluation of the linker region: identification of an exceptionally prominent role for the L-threonine substituentD L Boger, S L Colletti, S Teramoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1991
Demonstration of a pronounced effect of noncovalent binding selectivity on the (+)-CC-1065 DNA alkylation and identification of the pharmacophore of the alkylation subunitD L Boger, H Zarrinmayeh, S A Munk, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis of the vancomycin CDE ring systemD L Boger, R T Beresis, O Loiseleur, et al.
The Journal of Organic Chemistry|May 2, 2000
Total synthesis of ningalin B utilizing a heterocyclic azadiene Diels-Alder reaction and discovery of a new class of potent multidrug resistant (MDR) reversal agentsD L Boger, D R Soenen, C W Boyce, et al.
Tetrahedron|September 28, 2018
An alternative and convenient strategy for generation of substantial quantities of singly 5'-32P-end-labeled double-stranded DNA for binding studies: development of a protocol for examination of functional features of (+)-CC-1065 and the duocarmycins that contribute to their sequence-selective DNA alkylation propertiesD L Boger, S A Munk, H Zarrinmayeh, et al.
Pageof 9